Interestingly, recent investigations have revealed that overexpression of CXCL12 in MCF7 cell lines (Breast cancer) leads to upregulation of OCT4, Nanog, and SOX2 (DiNatale et al., 2022). Here, CXCL12 is linked to breast cancer.